Biotech Hangout Episode 73
Oct 3, 2023
In this episode of the podcast, the hosts discuss the state of the XBI and the challenges of raising capital. They also dive into the impact of the orphan cures act on the biotech industry. Other topics include the drug sparsent, competition in the ADC space, two-year data for a geographic atrophy drug, messaging and investor reaction, challenges in drug trials, and the growing interest in generative AI in healthcare.
Chapters
Transcript
Episode notes
1 2 3 4 5 6 7 8
Introduction
00:00 • 4min
The Impact of Regulatory Environment on the Biotech Industry
04:04 • 9min
Discussion on the Effect of Sparsent in Patients with IgA Nephropathy
13:17 • 3min
Competition between Daiichi and Gilead in ADC Space
16:34 • 7min
Analysis of Two Year Data for Geographic Atrophy Drug
23:48 • 2min
Analyzing Messaging and Investor Reaction
25:53 • 3min
Treberes CEO and Drug Trial Challenges
29:16 • 27min
Closing Thoughts and Looking Forward
55:49 • 5min